Home

Market Capitalization of Aptus Pharma Ltd

From Blinkx's GPT

No data available

Key Highlights

  • The Latest Trading Price of Aptus Pharma Ltd is ₹ 84.84 as of 30 Sep 16:01 .
Image

Aptus Pharma Ltd

NSE: APPL

Share Price

₹ 84.84

14.84 (21.20%)

stock direction

Last updated on: Sep 30, 2025

Market Price of Aptus Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Aptus Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

BlinkX Score for Aptus Pharma Ltd

Asset Value vs Market Value of Aptus Pharma Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of Market Cap

Key Valuation Metric of Aptus Pharma Ltd

No data available

Historical P/E Ratio of Aptus Pharma Ltd

No data available

* All values are in %

Historical Revenue of Aptus Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Aptus Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Aptus Pharma Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

About Aptus Pharma Ltd

  • Aptus Pharma Limited was originally incorporated as 'Aptus Pharma Private Limited', as a private limited company with the Registrar of Companies, Gujarat, pursuant to a Certificate of Incorporation dated August 12, 2010.
  • Subsequently, Company was converted into a public limited retaining the name as 'Aptus Pharma Limited' and a fresh certificate of incorporation dated December 12, 2024 was issued by the Registrar of Companies, Central Processing Centre. Company is engaged in the business of marketing, and distribution of finished pharmaceutical formulations.
  • While the Company does not own any manufacturing facilities, it operates through a contract manufacturing model with 7 units. under various arrangements.
  • It provide a diverse range of pharmaceutical products catering to various therapeutic categories including anti-infectives, gastrointestinal, antacids, anti-allergic and respiratory, nutritional supplements, pain management, neuro-psychiatric, cardiovascular, antidiabetic, lipid-lowering, and general wellness products.

Aptus Pharma Ltd News Hub

Shares of Aptus Pharma list in MT Group

The equity shares of Aptus Pharma (Scrip Code: 544529) are listed effective 30 September 2025 and ad

Read more

30 Sept 25

BSE SME Aptus Pharma cures listing-day jitters with premium opening

The scrip was listed at Rs 80.80, a premium of 15.43% over the initial public offer (IPO) price. The

Read more

30 Sept 25

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for null Market Cap

What is the market cap of Aptus Pharma Ltd?

As of September 30, 2025, Aptus Pharma Ltd has a market capitalization of ₹0.0, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Aptus Pharma Ltd's market capitalization?

Aptus Pharma Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Aptus Pharma Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Aptus Pharma Ltd's market capitalization change?

Aptus Pharma Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions